{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:00:15Z","timestamp":1793678415591,"version":"4.5.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["_1\/index"],"award-info":[{"award-number":["_1\/index"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["SKLOD2020OF03"],"award-info":[{"award-number":["SKLOD2020OF03"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["20ykzd09"],"award-info":[{"award-number":["20ykzd09"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.biopha.2020.110906","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T21:47:49Z","timestamp":1605217669000},"page":"110906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Combined inhibition of RNA polymerase I and mTORC1\/2 synergize to combat oral squamous cell carcinoma"],"prefix":"10.1016","volume":"133","author":[{"given":"Shanwei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huigen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110906_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2017.11.014","article-title":"Nanomedicine, an emerging therapeutic strategy for oral cancer therapy","volume":"76","author":"Marcazzan","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.biopha.2020.110906_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coms.2014.01.001","article-title":"Epidemiologic trends in head and neck cancer and aids in diagnosis","volume":"26","author":"Vigneswaran","year":"2014","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"10.1016\/j.biopha.2020.110906_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2020.110906_bib0020","first-page":"25","article-title":"Molecular mechanisms of chemoresistance in oral cancer","volume":"19","author":"Wang","year":"2016","journal-title":"Chin. J. Dent. Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006994","article-title":"Ribosomal DNA copy number amplification and loss in human cancers is linked to tumor genetic context, nucleolus activity, and proliferation","volume":"13","author":"Wang","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2020.110906_bib0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2020.110906_bib0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.biopha.2020.110906_bib0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1083\/jcb.153.1.169","article-title":"Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells","volume":"153","author":"Chen","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2020.110906_bib0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12192-016-0693-5","article-title":"Oxidative stress-induced DNA damage of mouse zygotes triggers G2\/M checkpoint and phosphorylates Cdc25 and Cdc2","volume":"21","author":"Zhang","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.biopha.2020.110906_bib0050","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1158\/2159-8290.CD-17-0177","article-title":"mTOR and HDAC inhibitors converge on the TXNIP\/thioredoxin pathway to cause catastrophic oxidative stress and regression of RAS-driven tumors","volume":"7","author":"Malone","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2020.110906_bib0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3389\/fphar.2018.00522","article-title":"Ionizing radiation-induced cellular senescence in normal, non-transformed cells and the involved DNA damage response: a mini review","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110906_bib0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41556-017-0033-8","article-title":"The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168","volume":"20","author":"Xie","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2020.110906_bib0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2443.2009.01337.x","article-title":"Fission yeast Ku protein is required for recovery from DNA replication stress","volume":"14","author":"Miyoshi","year":"2009","journal-title":"Genes Cells"},{"key":"10.1016\/j.biopha.2020.110906_bib0070","doi-asserted-by":"crossref","first-page":"33440","DOI":"10.18632\/oncotarget.7961","article-title":"PI3K\/Akt\/mTOR signaling pathway and targeted therapy for glioblastoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2020.110906_bib0075","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/1078-0432.CCR-16-2656","article-title":"Enrichment of PIK3-AKT-MTOR pathway activation in hepatic metastases from breast cancer","volume":"23","author":"Pierobon","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0080","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1158\/1538-7445.AM2013-2011","article-title":"Abstract 2011: the PI3K pathway is the most frequently mutated mitogenic pathway in HNSCC","volume":"73","author":"Hedberg","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/14728222.2015.1012157","article-title":"Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma","volume":"19","author":"Horn","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2020.110906_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.oraloncology.2012.12.016","article-title":"A phase II study of temsirolimus and erlotinib in patients with recurrent and\/or metastatic, platinum-refractory head and neck squamous cell carcinoma","volume":"49","author":"Bauman","year":"2013","journal-title":"Oral Oncol."},{"key":"10.1016\/j.biopha.2020.110906_bib0095","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1158\/1078-0432.CCR-12-1371","article-title":"Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model","volume":"18","author":"Sun","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0100","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1158\/1078-0432.CCR-12-2716","article-title":"PI3K\/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer","volume":"19","author":"Herzog","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0105","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1158\/0008-5472.CAN-10-3192","article-title":"Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer","volume":"71","author":"Patel","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0110","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-11-2824","article-title":"mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas","volume":"18","author":"Molinolo","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0115","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1158\/0008-5472.CAN-18-3525","article-title":"Metformin inhibits progression of head and neck squamous cell carcinoma by acting directly on carcinoma-initiating cells","volume":"79","author":"Wu","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2019.04.010","article-title":"Combined class I histone deacetylase and mTORC1\/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2","volume":"454","author":"Liang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2020.110906_bib0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1083\/jcb.201006040","article-title":"RNA polymerase I-specific subunits promote polymerase clustering to enhance the rRNA gene transcription cycle","volume":"192","author":"Albert","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2020.110906_bib0130","first-page":"1","article-title":"Rat 5S rDNA spacer sequences and chromosomal assignment of the genes to the extreme terminal region of chromosome 19","volume":"72","author":"Suzuki","year":"1996","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.biopha.2020.110906_bib0135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.molcel.2007.02.016","article-title":"Insights into transcription initiation and termination from the electron microscopy structure of yeast RNA polymerase III","volume":"25","author":"Fernandez-Tornero","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2020.110906_bib0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2020.110906_bib0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/ml300110s","article-title":"Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for cancer therapeutics","volume":"3","author":"Haddach","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2020.110906_bib0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bjh.14525","article-title":"RNA polymerase I inhibition with CX-5461 as a novel therapeutic strategy to target MYC in multiple myeloma","volume":"177","author":"Lee","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2020.110906_bib0155","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1158\/1538-7445.AM2016-1319","article-title":"Abstract 1319: a novel formulation of CX-5461, a small-molecule inhibitor of rRNA synthesis, and its use for treatment of acute myeloid leukemia models","volume":"76","author":"Leung","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/2159-8290.CD-14-0673","article-title":"Combination therapy targeting ribosome biogenesis and mRNA translation synergistically extends survival in MYC-driven lymphoma","volume":"6","author":"Devlin","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2020.110906_bib0165","doi-asserted-by":"crossref","first-page":"14432","DOI":"10.1038\/ncomms14432","article-title":"CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.110906_bib0170","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1073\/pnas.1921649117","article-title":"The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning","volume":"117","author":"Bruno","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110906_bib0175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41417-018-0072-8","article-title":"c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma","volume":"26","author":"Li","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2020.110906_bib0180","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41418-019-0423-5","article-title":"Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop","volume":"27","author":"Zhao","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2020.110906_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006771","article-title":"Ribosomal DNA copy number loss and sequence variation in cancer","volume":"13","author":"Xu","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2020.110906_bib0190","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tig.2019.07.011","article-title":"Ribosomal DNA and the nucleolus as keystones of nuclear architecture, organization, and function","volume":"35","author":"Cerqueira","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.biopha.2020.110906_bib0195","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1073\/pnas.1720391115","article-title":"Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers","volume":"115","author":"Udugama","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110906_bib0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1004199902680","article-title":"Chromosomal analysis of repeated DNAs in the rainbow wrasse Coris julis (Pisces, Labridae)","volume":"108","author":"Mandrioli","year":"2000","journal-title":"Genetica"},{"key":"10.1016\/j.biopha.2020.110906_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002749","article-title":"Cohesin proteins promote ribosomal RNA production and protein translation in yeast and human cells","volume":"8","author":"Bose","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2020.110906_bib0210","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1093\/nar\/gkr1040","article-title":"mTOR signaling regulates the processing of pre-rRNA in human cells","volume":"40","author":"Iadevaia","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0215","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1038\/sj.onc.1209883","article-title":"Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases","volume":"25","author":"Mayer","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2020.110906_bib0220","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1038\/ncomms5850","article-title":"Ribosomal DNA copy number is coupled with gene expression variation and mitochondrial abundance in humans","volume":"5","author":"Gibbons","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.110906_bib0225","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1126\/science.1179044","article-title":"Abundance of ribosomal RNA gene copies maintains genome integrity","volume":"327","author":"Ide","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.110906_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41586-018-0769-8","article-title":"Dna2 nuclease deficiency results in large and complex DNA insertions at chromosomal breaks","volume":"564","author":"Yu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110906_bib0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-017-0611-1","article-title":"Cdk5 links with DNA damage response and cancer","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2020.110906_bib0240","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/ptr.6302","volume":"33","author":"Roy","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/1538-7445.AM2015-31","article-title":"Abstract 31: WEE1 kinase inhibition enhances PI3K inhibitor response in p53 deficient gliomas","volume":"75","author":"Wu","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0255","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1101\/gr.229716.117","article-title":"Coregulation of ribosomal RNA with hundreds of genes contributes to phenotypic variation","volume":"28","author":"Li","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0260","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00428-014-1641-3","article-title":"Complex interactions between the components of the PI3K\/AKT\/mTOR pathway, and with components of MAPK, JAK\/STAT and Notch-1 pathways, indicate their involvement in meningioma development","volume":"465","author":"El-Habr","year":"2014","journal-title":"Virchows Arch."},{"key":"10.1016\/j.biopha.2020.110906_bib0265","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/1878-0261.12109","article-title":"GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance","volume":"11","author":"Baumann","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2020.110906_bib0270","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.dnarep.2007.05.007","article-title":"Repair of idarubicin-induced DNA damage: a cause of resistance?","volume":"6","author":"Dartsch","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.biopha.2020.110906_bib0275","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-13-2136","article-title":"The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells","volume":"20","author":"Hayman","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0280","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1158\/1541-7786.MCR-11-0592","article-title":"Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair","volume":"10","author":"Toulany","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0285","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.415","article-title":"PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways","volume":"5","author":"Chang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2020.110906_bib0290","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/carcin\/bgz052","article-title":"Variation in ribosomal DNA copy number is associated with lung cancer risk in a prospective cohort study","volume":"40","author":"Hosgood","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2020.110906_bib0295","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1093\/nar\/gkg468","article-title":"Replication of damaged DNA in vitro is blocked by p53","volume":"31","author":"Zhou","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.110906_bib0300","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.molonc.2011.05.002","article-title":"Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress","volume":"5","author":"Dereli-Oz","year":"2011","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2020.110906_bib0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molcel.2018.08.036","article-title":"Genomic copy-number loss is rescued by self-limiting production of DNA circles","volume":"72","author":"Mansisidor","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2020.110906_bib0310","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molcel.2018.11.029","article-title":"RNA polymerase I activators count and adjust ribosomal RNA gene copy number","volume":"73","author":"Iida","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2020.110906_bib0315","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/fox001","article-title":"Ribosomal DNA stability is supported by many\u2019 buffer genes\u2019-introduction to the yeast rDNA stability database","volume":"17","author":"Kobayashi","year":"2017","journal-title":"FEMS Yeast Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:01:29Z","timestamp":1792720889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220310982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":63,"alternative-id":["S0753332220310982"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110906","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined inhibition of RNA polymerase I and mTORC1\/2 synergize to combat oral squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110906"}}